Author Guidelines

1. AIM AND SCOPE

MGRJPAR publishes original, high-quality contributions that advance the science and practice of physiotherapy, foster evidence-based clinical practice, and support a research-driven culture among students, clinicians, and researchers. Submissions are welcomed across the full spectrum of physiotherapy and allied rehabilitation sciences, including but not limited to:

• Clinical research and evidence-based practice (RCTs, cohort studies, pilot investigations, systematic reviews, meta-analyses, case reports)
• Clinical practice and therapeutic applications (manual therapy, electrotherapy, exercise prescription, functional training, condition-specific protocols)
• Technology and innovation in rehabilitation (robotics, tele-rehabilitation, wearables, AI and data analytics)
• Interdisciplinary and collaborative care models
• Health policy, physiotherapy education, and advocacy

2. TYPES OF MANUSCRIPTS ACCEPTED

3. MANUSCRIPT STRUCTURE

All original research submissions should follow the section order and content shown below, which reflects the journal's established format:

Other article types should adapt this structure to their format while retaining numbered references throughout:

• Case Report / Case Series — replace Methods/Results with Case Presentation (patient history, examination, intervention, outcome).
• Narrative Review — replace Methods with an overview of the search/selection approach used, then organize the body by theme rather than by Results/Discussion.
• Study Protocol — follows Introduction, Methods (as planned), and Ethical/Registration details in place of Results; no Discussion or Conclusion of findings, since none yet exist.
• Short Communication / Brief Report — condensed Introduction, Methods, Results, and Discussion, combined where appropriate.
• Letter to the Editor — no abstract or keywords required; brief introduction of the issue, the author's point, and a short reference list (typically under 10 references).

4. TITLE PAGE REQUIREMENTS

• Article type (e.g., "Original Research Article") stated above the title.
• Concise, specific title reflecting the study design and population, plus a short running title (max 50 characters) for the header.
• Full names of all authors with affiliation numbers as superscripts (e.g., Author Name¹).
• Each affiliation listed in full below the author block: designation, department/faculty, institution, city.
• ORCID ID for each author, where available.
• Corresponding author clearly indicated, with email address and a contact number for editorial correspondence.
• Received / Accepted / Published dates are inserted by the editorial office — authors should not fill this in.

5. ABSTRACT AND KEYWORDS

The abstract must be structured under four headings — Background, Methods, Results, and Conclusion — within approximately 250–300 words, with no citations or abbreviations that have not been defined. Provide 4–6 keywords immediately after the abstract, ordered alphabetically or by relevance.

6. FORMATTING SPECIFICATIONS

• Font: Times New Roman, 12 pt for body text; headings may use a bold sans-serif for hierarchy.
• Spacing: 1.5 line spacing throughout the manuscript.
• Margins: 1 inch on all sides, US Letter or A4.
• Word count: Original research 3,000–4,500 words; systematic reviews / meta-analyses / narrative reviews up to 6,000 words; case reports and case series 1,500–2,500 words; short communications / brief reports 1,200–2,000 words; technical innovation articles 2,000–3,000 words; scholarly commentaries / perspectives 1,000–2,000 words; letters to the editor 500–800 words. (All limits exclude the abstract and reference list.)
• Headings: Use the hierarchy Introduction → Methods (with clearly labeled subsections) → Results → Discussion → Conclusion → Limitations of the Study → Recommendations for Future Research → References.
• Tables: Numbered consecutively (Table 1, Table 2, …) with a descriptive title above the table; cite every table in the text before it appears.
• Statistics: Report the software and version used, significance threshold (e.g., P ≤ 0.05), and the specific tests applied (e.g., paired t-test, independent t-test), including normality testing where relevant.

7. REFERENCE STYLE

References follow the Vancouver (numbered) system:

• Number references consecutively in the order they are first cited in the text, using square brackets, e.g. [1], [3,4], [5–7].
• List references in numerical order (not alphabetical) in the Reference section.
• Format: Author Surname Initials. Title of article. Journal Abbreviation. Year;Volume(Issue):Pages. Include DOI where available.
• Cite a maximum of 50 references for original research and 100 for systematic reviews, favouring sources from the last 10 years where possible.

8. ETHICAL CONSIDERATIONS

• Studies involving human participants must state that written informed consent was obtained from all participants.
• Institutional Ethics/IRB approval number and approving body must be stated in the Methods section.
• Clinical trials should include a trial registration number where applicable.
• Inclusion and exclusion criteria must be explicitly stated for any interventional study.
• Authors must disclose any conflicts of interest and sources of funding.

9. AUTHORSHIP CRITERIA

Authorship is reserved for individuals who have made a substantial contribution to the study — its conception or design, data acquisition, analysis or interpretation — and who have participated in drafting or critically revising the manuscript. Every listed author must approve the final version submitted and take public responsibility for the accuracy and integrity of the work. Contributors who assisted the study but do not meet these criteria (e.g., data collection support, general supervision) should be named in an Acknowledgements section rather than listed as authors.

10. CONFLICT OF INTEREST, FUNDING, AND PERMISSIONS

• Authors must disclose any financial, institutional, or personal relationships that could be perceived to influence the work, or state explicitly that none exist.
• All sources of funding or sponsorship supporting the research must be named in the manuscript.
• Where a manuscript reproduces a table, figure, image, or substantial text from a previously published or copyrighted source, written permission from the copyright holder must be obtained and submitted alongside the manuscript.

11. PEER REVIEW PROCESS

All original research, review, and technical innovation submissions undergo double-blind peer review by at least two independent reviewers with relevant expertise. Case reports and commentaries may undergo editorial review supplemented by peer review at the editor's discretion. Authors will typically receive an initial editorial decision within [insert your journal's target turnaround time], and are given a defined window to submit revisions.

12. PUBLICATION ETHICS AND PLAGIARISM

MGRJPAR's editorial practices are guided by internationally recognized standards for research and publication integrity, including safeguards against plagiarism, data fabrication or falsification, duplicate submission, and undisclosed conflicts of interest.

• Manuscripts must be original, unpublished, and not under consideration elsewhere at the time of submission.
• All submissions are screened for textual similarity; content found to exceed the journal's acceptable threshold will be returned for revision or rejected.
• Any use of generative AI tools in manuscript preparation must be disclosed in the Methods or Acknowledgements section.
• The editorial board reserves the right to retract, correct, or remove published content found to involve ethical misconduct, data fabrication, or copyright infringement, even after publication.

13. ARTICLE PROCESSING CHARGES

MGRJPAR is a fully open-access journal. No article processing charges, submission fees, or publication fees are levied on authors at any stage of manuscript handling, from submission through peer review to final publication.

14. LANGUAGE AND PUBLICATION FREQUENCY

Manuscripts must be submitted in English. MGRJPAR publishes four issues per year, released quarterly in January, April, July, and October.

15. SUBMISSION DECLARATION

By submitting a manuscript, the corresponding author confirms, on behalf of all listed authors, that: the work is original and has not been published previously (except as an abstract, thesis, or disclosed preprint); it is not under consideration elsewhere; all authors have approved the final version and take responsibility for its content; and any third-party or copyrighted material included has the necessary permissions.

16. SUBMISSION CHECKLIST

1. Title page complete with author affiliations and corresponding author details
2. Structured abstract (250–300 words) and 4–6 keywords
3. Manuscript follows the required section order and heading hierarchy
4. Tables and figures numbered, titled, and cited in text
5. Statistical methods and significance thresholds clearly reported
6. Ethical approval / consent statement included
7. References numbered in Vancouver style, in order of citation
8. Conflict of interest and funding statements included
9. Manuscript proofread for language and formatting consistency

17. HOW TO SUBMIT

Manuscripts should be submitted as a single Word (.docx) file, with figures and images embedded in place and also supplied separately at high resolution, to [https://drmgrdujhs.org/index.php/mgrjpar/login]. Include a brief cover letter confirming the work is original and has not been submitted elsewhere.